Global Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Forecast 2024-2030- Product Image

Sale

Global Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 5666498

UP TO €848EUR$875USD£726GBP OFF until Dec 31^st 2024

The Specialty Generics Market size was estimated at USD 84.86 billion in 2023, USD 93.56 billion in 2024, and is expected to grow at a CAGR of 10.73% to reach USD 173.25 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Specialty Generics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Specialty Generics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Specialty Generics Market, highlighting leading vendors and their innovative profiles. These include Akorn Operating Company LLC, Apotex Inc., Aspen Group, Aurobindo Pharma Limited, Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International plc, Fresenius Kabi AG, Generic Specialties, Inc., Hikma Pharmaceuticals PLC, Lupin Limited, Mallinckrodt Pharmaceuticals, Novartis AG, Pfizer Inc., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Specialty Generics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Injectables
- Oral Drugs
Application
- Hepatitis C
- Inflammatory Conditions
- Multiple Sclerosis
- Oncology
End-Use
- Hospital Pharmacy
- Retail Pharmacy
- Specialty Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Specialty Generics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Specialty Generics Market?
What are the technology trends and regulatory frameworks in the Specialty Generics Market?
What is the market share of the leading vendors in the Specialty Generics Market?
Which modes and strategic moves are suitable for entering the Specialty Generics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Specialty Generics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of specialty generic medicines for the treatment of complex chronic diseases
5.1.1.2. Presence of supportive regulatory policies regarding the approval of new products
5.1.1.3. Significant investments for drug development
5.1.2. Restraints
5.1.2.1. High costs associated with specialty generics
5.1.3. Opportunities
5.1.3.1. Availability of medically advanced companies and proliferating research & development programs
5.1.3.2. High patient population and growing demand for affordable healthcare facilities
5.1.4. Challenges
5.1.4.1. Concerns regarding development and marketing costs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Specialty Generics Market, by Type

6.1. Introduction
6.2. Injectables
6.3. Oral Drugs

7. Specialty Generics Market, by Application

7.1. Introduction
7.2. Hepatitis C
7.3. Inflammatory Conditions
7.4. Multiple Sclerosis
7.5. Oncology

8. Specialty Generics Market, by End-Use

8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy
8.4. Specialty Pharmacy

9. Americas Specialty Generics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Specialty Generics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Specialty Generics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Akorn Operating Company LLC
13.1.2. Apotex Inc.
13.1.3. Aspen Group
13.1.4. Aurobindo Pharma Limited
13.1.5. Bausch Health Companies Inc.
13.1.6. Cipla Limited
13.1.7. Dr. Reddy's Laboratories Ltd.
13.1.8. Endo International plc
13.1.9. Fresenius Kabi AG
13.1.10. Generic Specialties, Inc.
13.1.11. Hikma Pharmaceuticals PLC
13.1.12. Lupin Limited
13.1.13. Mallinckrodt Pharmaceuticals
13.1.14. Novartis AG
13.1.15. Pfizer Inc.
13.1.16. STADA Arzneimittel AG
13.1.17. Sun Pharmaceutical Industries Ltd.
13.1.18. Teva Pharmaceutical Industries Ltd.
13.1.19. Viatris Inc.
13.1.20. Zydus Group
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. SPECIALTY GENERICS MARKET RESEARCH PROCESS
FIGURE 2. SPECIALTY GENERICS MARKET SIZE, 2023 VS 2030
FIGURE 3. SPECIALTY GENERICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SPECIALTY GENERICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SPECIALTY GENERICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SPECIALTY GENERICS MARKET DYNAMICS
FIGURE 7. SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SPECIALTY GENERICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SPECIALTY GENERICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. SPECIALTY GENERICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. SPECIALTY GENERICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPECIALTY GENERICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. SPECIALTY GENERICS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SPECIALTY GENERICS MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. SPECIALTY GENERICS MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SPECIALTY GENERICS MARKET SIZE, BY INFLAMMATORY CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SPECIALTY GENERICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SPECIALTY GENERICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 14. SPECIALTY GENERICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SPECIALTY GENERICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SPECIALTY GENERICS MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. CANADA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES SPECIALTY GENERICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. CHINA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. INDIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA SPECIALTY GENERICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. ITALY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. POLAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. QATAR SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM SPECIALTY GENERICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. SPECIALTY GENERICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. SPECIALTY GENERICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. SPECIALTY GENERICS MARKET LICENSE & PRICING

Companies Mentioned

Akorn Operating Company LLC
Apotex Inc.
Aspen Group
Aurobindo Pharma Limited
Bausch Health Companies Inc.
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Endo International plc
Fresenius Kabi AG
Generic Specialties, Inc.
Hikma Pharmaceuticals PLC
Lupin Limited
Mallinckrodt Pharmaceuticals
Novartis AG
Pfizer Inc.
STADA Arzneimittel AG
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Zydus Group

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 93.56 Billion
Forecasted Market Value ( USD ) by 2030	$ 173.25 Billion
Compound Annual Growth Rate	10.7%
Regions Covered	Global
No. of Companies Mentioned	20

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3270EUR$3,374USD£2,801GBP €3633EUR$3,749USD£3,112GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4142EUR$4,274USD£3,548GBP €4602EUR$4,749USD£3,942GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5014EUR$5,174USD£4,295GBP €5571EUR$5,749USD£4,772GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5887EUR$6,074USD£5,042GBP €6541EUR$6,749USD£5,602GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7631EUR$7,874USD£6,536GBP €8479EUR$8,749USD£7,262GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Generic Drugs Market by Type (Simple Generic, Specialty Generic), Route of Administration (Inhalable, Injectable, Oral), Indication, Distribution - Forecast 2024-2030

Specialty Generics Global Market Report 2024

Specialty Generics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

Specialty Generics - Global Strategic Business Report

Global Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type (Injectables, Oral Drugs, and Others), By Application, By End Use (Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy), By Regional Outlook and Forecast, 2023 - 2030